Evaxion Biotech AS a clinicalstage TechBio company specializing in AIImmunology powered vaccines has achieved a significant milestone in its EVX Phase trial for metastatic melanoma

ABVC BioPharma Inc has unveiled a significant licensing deal with OncoX a company specializing in oncology dietary supplements with the goal of advancing treatments for NonSmall Cell Lung Cancer

TaiGen Biotechnology Company Limited has announced today that its business partner Joincare Pharmaceutical has concluded the unblinding process for the phase III study of the influenza antiviral TG Initial findings indicate that TG significantly reduced the median time for alleviation of all influen...

Enlivex Therapeutics Ltd has received authorization from the Danish Medicines Agency to expand its Phase III trial for Allocetra into Denmark This development follows the initial approval

Precision BioSciences Inc a leading gene editing company has declared the anticipated return of three programs previously under Prevail Therapeutics Inc a subsidiary of Eli Lilly and Company

SCG Cell Therapy and the Agency for Science Technology and Research have announced the inauguration

DiaMedica Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardiorenal disease today announced the first patient

Essential Pharma an international specialty pharma group focused on ensuring that patients have sustainable access to low volume clinically differentiated niche pharmaceutical products across key

Clearmind Medicine Inc a biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems today announced an

Merck a leading science and technology company has launched the first allinone validated genetic stability assay of its kind The Aptegra CHO genetic stability assay leverages whole genome

For pharma and biopharma companies building quality into your products from an early stage is a key factor in regulatory approval and market successThus the FDA mentions Design of Experiments DoEas an essential tool for achieving both regulatory compliance and faster time to market To help you build...

GRI Bio Inc a biotechnology company advancing an innovative pipeline of Natural Killer T cell modulators for the treatment of inflammatory fibrotic and autoimmune diseases today announced that the Korean